Brokerages Set Applied Therapeutics, Inc. Target Price at 12.50

APLT Stock  USD 0.53  0.01  1.85%   
Slightly above 68% of Applied Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Applied Therapeutics suggests that many traders are alarmed. Applied Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Applied Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
Shares of Applied Therapeutics, Inc. have been assigned a consensus rating of Buy from the six brokerages that are currently covering the company, MarketBeat reports. Five analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price

Read at thelincolnianonline.com
news
  

Applied Therapeutics Current Investor Sentiment

Comfort Level 32

 Alarmed

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Applied Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Applied Therapeutics.

Applied Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Applied Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Applied Therapeutics Historical Investor Sentiment

Investor biases related to Applied Therapeutics' public news can be used to forecast risks associated with an investment in Applied. The trend in average sentiment can be used to explain how an investor holding Applied can time the market purely based on public headlines and social activities around Applied Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Applied Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Applied Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Applied Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Applied Therapeutics.

Applied Therapeutics Fundamental Analysis

We analyze Applied Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Applied Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Applied Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Return On Asset

Return On Asset Comparative Analysis

Applied Therapeutics is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Applied Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Applied Therapeutics stock to make a market-neutral strategy. Peer analysis of Applied Therapeutics could also be used in its relative valuation, which is a method of valuing Applied Therapeutics by comparing valuation metrics with similar companies.

Peers

Applied Therapeutics Related Equities

STTKShattuck Labs   25.55   
0%
100.0%
ORICOric Pharmaceuticals   6.88   
0%
26.0%
LYRALyra Therapeutics   5.80   
0%
22.0%
GANXGain Therapeutics   5.73   
0%
22.0%
MOLNMolecular Partners   4.70   
0%
18.0%
LTRNLantern Pharma   3.78   
0%
14.0%
ACRVAcrivon Therapeutics,   2.79   
0%
10.0%
PMVPPmv Pharmaceuticals   1.42   
0%
5.0%
SEERSeer   0.90   
0%
3.0%
TERNTerns Pharmaceuticals   0.00   
0%
0%
HOOKHookipa Pharma   1.12   
4.0%
0%
ANEBAnebulo Pharmaceuticals   1.60   
6.0%
0%
XFORX4 Pharmaceuticals   1.82   
7.0%
0%
CGEMCullinan Oncology   1.83   
7.0%
0%
MLYSMineralys Therapeutics,   3.24   
12.0%
0%
CCCCC4 Therapeutics   3.46   
13.0%
0%
VINCVincerx Pharma   3.51   
13.0%
0%
INABIn8bio   3.70   
14.0%
0%
BCABBioatla   7.32   
28.0%
0%
DAWNDay One   10.41   
40.0%
0%

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.